Home>Topics>>Cramer's Mad Money - The Unsinkable Biogen IDEC (1/8/13)
Cramer's Mad Money - The Unsinkable Biogen IDEC (1/8/13)
Jim Cramer's Stock Picks from Seeking Alpha
Wed, 9 Jan 2013
By SA Editor Miriam Metzinger : Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday January 8. CEO Interview: George Sangos, Biogen IDEC ( BIIB ) A recent clinical trial that ended in disappointment didn't bring Biogen IDEC ( BIIB ) down; the stock barely budged ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.